Using kaempferol to treat A549 cells can upregulate the PTEN protein and reduce p-PI3K and p-Akt protein, thus ultimately treating lung cancer by affecting the PI3K–Akt pathway (58). This evidence concerns the gene AKT1 and lung cancer.